NAD+ is not a peptide. It is a naturally occurring coenzyme made from two linked nucleotides, while peptides consist of linked amino acids. The term “NAD peptide” is informal language used by some wellness clinics for NAD+ injections, infusions, or treatments offered alongside peptide therapy.

So, a NAD+ injection does not become a peptide simply because it comes through a needle. 

This article explains the difference, what people may mean by “NAD peptide therapy,” and what human research says about NAD+ infusions and oral precursors.

Key Takeaways:

• NAD+ is a coenzyme made from nucleotides, not a peptide made from amino acids.

• “NAD peptide” is an informal term used for NAD+ injections, infusions, or related clinic services.

• Human research on injected NAD+ remains limited and has not confirmed broad anti-aging benefits.

• NMN and NR are oral NAD+ precursors with more human research, though results remain mixed.

What Is NAD+?

NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme found in every living cell. It helps enzymes carry out reactions involved in cellular energy, DNA-related activity, and cell signaling.

NAD exists mainly in two related forms: NAD+ and NADH. NAD+ accepts electrons during chemical reactions, while NADH carries those electrons to other parts of the cell. You can think of them as two sides of the same rechargeable carrier.

This process helps cells turn nutrients from food into usable energy. NAD+ also acts as a supporting molecule for enzymes involved in DNA maintenance, stress responses, gene activity, and communication between cells.

That does not mean that raising NAD+ will automatically improve energy, slow aging, or prevent disease. NAD+ has an established role in human biology, but changing its levels through supplements or injections may not produce the same results in every person.

Is NAD a Peptide?

No, NAD+ is not a peptide. NAD+ consists of two nucleotides joined together, while a peptide consists of amino acids linked in a chain. They belong to different biochemical categories.

The confusion comes less from chemistry and more from how wellness services are marketed. NAD+ treatments and peptide treatments may appear on the same clinic menu, but that does not make them the same type of substance.

A peptide may act as a signaling molecule, hormone, structural component, or part of a larger protein. NAD+ works mainly as a coenzyme and cellular substrate. Their functions can sometimes overlap within the same biological pathway, but their structures remain different.

Why Do People Call It an “NAD Peptide”?

The phrase NAD peptide appears mainly in wellness marketing rather than biochemistry textbooks or clinical terminology.

Several factors may explain the wording:

• Clinics offer both services: NAD+ infusions and peptide injections may appear beside each other in the same treatment package.

• Both can involve needles:Consumers may group injectable products together, even when the substances are chemically unrelated.

• Marketing language gets simplified:A clinic may use “NAD peptide therapy” as an umbrella phrase for several wellness services.

• NAD+ is linked with cellular signaling:Since some peptides also influence signaling pathways, the terms may become mixed in casual descriptions.

“NAD peptide” is not a precise scientific name. When you see it online, it helps to check the ingredient, delivery method, dose, and credentials of the provider rather than relying on the label alone.

What Does “NAD Peptide Therapy” Usually Mean?

There is no single treatment officially defined as NAD peptide therapy. Different clinics and websites may use the phrase for different products.

It may refer to:

• An NAD+ IV infusion:NAD+ is delivered into a vein over a set period.

• A NAD+ injection: The product may be given into muscle or under the skin.

• Injectable nicotinamide riboside: NR is a precursor the body can use to make NAD+, but it is not NAD+ itself.

• NAD+ combined with separate peptides: A clinic may provide both as part of the same program.

• An oral NMN or NR supplement: Some pages inaccurately group these NAD+ precursors with peptides or injectable NAD+.

The phrase NAD plus peptide may also describe two separate therapies used together rather than a single compound. Consumers should ask for the exact product name because NAD+, NMN, NR, and peptides are not interchangeable.

How Do NAD+ Injections and IV Infusions Work?

An IV infusion delivers NAD+ directly into a vein. Intramuscular injections place it into muscle, while subcutaneous injections place it into the fatty tissue beneath the skin.

These routes affect how quickly a substance enters circulation:

• IV infusion: Enters the bloodstream directly and may be given gradually over an extended session.

• Intramuscular injection: Absorbs from muscle tissue over time.

• Subcutaneous injection:Absorbs from the tissue beneath the skin, commonly at a slower rate than an IV.

A 2019 pilot study followed eight healthy adults receiving NAD+ and three receiving saline during a six-hour infusion. 

Researchers measured NAD+ and related metabolites in plasma and urine. They found that NAD+ metabolism changed during the infusion, including a 538% increase in urinary NAD+ excretion at the six-hour point compared with the 30-minute measurement (1).

The study helps explain how infused NAD+ may be processed and removed from the body. It did not test energy, cognition, recovery, biological age, weight, or long-term health. It also included only 11 people, so it cannot confirm broad wellness benefits.

Protocols also vary between providers. The amount given, infusion speed, treatment length, and frequency may differ considerably. This makes it harder to compare clinic claims with published research.

What Are the Possible Benefits of NAD+ Therapy?

NAD+ plays several important roles inside cells. Still, its established biological functions should not be confused with proven benefits from an injection or infusion.

May Raise NAD-Related Levels or Metabolites

Direct infusion changes the way NAD+ and its breakdown products appear in blood and urine.

In the 2019 pilot study, researchers observed changes in several NAD-related metabolites during the six-hour infusion (1). This shows that the body responded to the administered NAD+, but the study did not establish a lasting increase in intracellular NAD+ across different tissues.

A 2026 systematic review found that NAD+-raising interventions showed clear biological activity. However, the reviewers found that evidence for anti-aging and general wellness outcomes remained inconclusive. Direct IV NAD+ research mainly provided pharmacokinetic information rather than eligible clinical outcome data (2).

Put simply, changing a biomarker is not the same as showing that people feel better, function better, or stay healthier.

May Support Cellular Energy Processes

NAD+ helps enzymes transfer electrons during reactions that turn carbohydrates, fats, and proteins into cellular energy. Without enough NAD+, these reactions would not run normally.

This biological role is sometimes shortened into the claim that NAD+ therapy “gives you energy.” That wording goes further than the evidence.

An infusion may alter NAD-related metabolites, but researchers have not firmly shown that NAD+ injections raise everyday energy or reduce fatigue in healthy adults. Energy levels can also depend on sleep, nutrition, stress, hormones, fitness, illness, and many other factors.

Other Wellness Claims Remain Under Study

NAD+ injections are promoted for several purposes, including:

• Mental clarity

• Exercise recovery

• Metabolic health

• Fatigue

• Healthy aging

• Cellular repair

• Addiction recovery

Research into NAD biology gives scientists reasonable grounds to study these areas. Direct clinical support for injected NAD+ remains thin, especially for healthy people seeking general wellness results.

A recent study comparing commercial IV NAD+ and IV NR reported different tolerability and metabolic responses between the two groups. The NAD+ group experienced more gastrointestinal symptoms, increased heart rate, and chest pressure during infusion. 

These effects resolved after the infusions ended, but the study did not establish anti-aging or broad wellness benefits (3).

Longer randomized trials with clear health outcomes are still needed.

NAD+ Injection Side Effects and Safety

NAD+ injections and infusions may cause side effects. The experience may depend on the dose, delivery method, infusion speed, provider, and the individual receiving it.

Reported or possible concerns include:

• Nausea: Gastrointestinal symptoms have been reported during NAD+ infusions.

• Abdominal discomfort: Some people may experience cramping or stomach pressure.

• Headache: Head discomfort may occur during or after an infusion.

• Flushing: A person may feel warm or notice temporary skin redness.

• Chest pressure or discomfort: One recent infusion study reported chest pressure among people receiving IV NAD+ (3).

• Changes in heart rate: Increased heart rate was also reported during NAD+ infusions in that study (3).

• Injection-site reactions: Intramuscular and subcutaneous injections may cause pain, swelling, redness, or bruising.

• Infection or contamination: Any injection can carry infection risks when sterile procedures are not followed.

• Unknown long-term risks: Researchers have not established the long-term safety of repeated NAD+ injections for general wellness.

A systematic review of NAD+ and NADH products found that the available studies covered different conditions, doses, and delivery methods. This variation made broad safety and effectiveness conclusions difficult (4).

NAD+ injections should take place under qualified medical supervision. People who are pregnant, breastfeeding, managing a health condition, or taking regular medication should discuss the risks with a licensed healthcare professional.

Home injection instructions and unverified injectable products bring added risks. Product purity, sterility, storage, and dose accuracy all matter.

NAD+ Injections vs. NMN and NR Supplements

NAD+ injections, NMN, and NR are connected through the same metabolic system, but they are different substances and delivery methods.

NMN stands for nicotinamide mononucleotide. NR stands for nicotinamide riboside. The body can use both as building materials in pathways that produce NAD+.

A 2025 meta-analysis reviewed 12 randomized studies involving 513 participants. NMN supplementation raised blood NAD-related levels, but most clinically meaningful outcomes did not differ significantly from the control groups (5).

That finding captures the current evidence well. Oral precursors can influence NAD biomarkers, but researchers are still working out when those changes lead to meaningful health outcomes.

One randomized trial in 25 postmenopausal women with prediabetes found that 250 mg of NMN daily for 10 weeks improved muscle insulin sensitivity and insulin signaling compared with placebo (6). The result is interesting, but it came from a specific group and should not be extended to every adult.

NMN, NR, and injected NAD+ should not be treated as direct substitutes. Their absorption, conversion, tissue availability, cost, and supporting research differ.

Is NAD+ Peptide Therapy Worth It?

NAD+ peptide therapy is not a scientifically precise treatment category, and there is not enough evidence to say NAD+ injections provide reliable anti-aging or general wellness benefits. NAD+ is biologically important, but it is not a peptide.

Direct delivery may alter blood and urine metabolites. That is different from proving better energy, cognition, recovery, metabolism, or longevity.

Cost deserves attention too. IV treatments may involve repeated clinic visits and lengthy sessions. Some people also experience discomfort that requires a slower infusion rate. A recent study found that NAD+ infusions took an average of 97 minutes, compared with 37 minutes for IV NR, partly because of moderate to severe symptoms in the NAD+ group (3).

People considering a NAD+ injection may want to ask:

• What substance is being administered?

• Is it NAD+, NMN, NR, or a separate peptide?

• What dose and delivery route will be used?

• What human evidence supports the stated purpose?

• Who will administer it?

• How is sterility checked?

• What side effects require the infusion to stop?

• What will the full treatment plan cost?

Oral NAD+ precursors have a larger human evidence base than direct NAD+ injections. Even so, they have not been shown to reverse aging, and their effects on health outcomes remain mixed.

A Research-Led Way to Support NAD+ Production

NMN is not oral NAD+, nor is it a peptide. It is a naturally occurring precursor that the body can use within its NAD+ production pathways.

Human trials suggest that oral NMN can raise NAD-related biomarkers, although benefits beyond those biomarker changes are less consistent (5). This makes transparent dosing and realistic expectations especially important.

At Omre, we use 500 mg of 99% pure NMN alongside 500 mg of micronized trans-resveratrol and 5 mg of BioPerine. 

The formula provides an oral NAD+ precursor in a clearly stated dose, offering another route for people who are not looking for injections or lengthy infusions.

Omre NMN + Resveratrol is also third-party tested for potency and purity. It is not presented as an injection replacement or a way to reverse aging. Instead, it offers a convenient oral option built around clearly identified ingredients and research-informed amounts.

Final Words

NAD+ is a coenzyme made from two nucleotides. It is not a peptide, even when it is administered through an injection or offered beside peptide therapy.

The phrase “NAD peptide” is mainly informal marketing language. Depending on the provider, it could refer to an NAD+ infusion, NAD+ injection, injectable NR, a combination of NAD+ and separate peptides, or even an oral precursor described incorrectly.

Early infusion studies show that administered NAD+ changes blood and urine metabolites. They do not yet confirm broad benefits for energy, recovery, cognition, healthy aging, or longevity. NMN and NR have more human research as oral precursors, but improvements in clinical outcomes remain mixed.

No NAD+ delivery method has been proven to reverse aging. Anyone considering an injectable product should first confirm what it contains and speak with a qualified medical professional.

For people who prefer an oral approach, Omre NMN + Resveratrol combines 500 mg of NMN with micronized trans-resveratrol and BioPerine in a transparent, third-party-tested formula.

FAQs

Is NAD+ considered a peptide?

No, NAD+ is not a peptide. It is a dinucleotide coenzyme made from two linked nucleotides, while peptides are made from chains of amino acids. Receiving NAD+ through an injection does not change its chemical category.

What is NAD peptide therapy?

“NAD peptide therapy” is an informal term that may describe NAD+ injections or infusions offered by wellness clinics. It can also refer to NAD+ used alongside separate peptide treatments. Since the phrase has no single scientific definition, consumers should ask for the exact ingredient and delivery method.

What does an NAD peptide injection contain?

A product described as a NAD peptide injection may contain NAD+, but the name alone does not confirm the ingredient. Some providers may use the term for injectable NR or a program combining NAD+ with a separate peptide. The product label and provider should identify the substance, dose, route, and other ingredients.

Are NAD+ injections better than NMN supplements?

There is not enough comparative research to say NAD+ injections are better than oral NMN. IV NAD+ studies remain limited and focus largely on metabolism and short-term tolerability. NMN has more randomized human trials, but its effects on meaningful health outcomes have been mixed.

What are the risks of NAD+ injections?

Possible risks include nausea, abdominal discomfort, headache, flushing, changes in heart rate, chest pressure, and injection-site reactions. Poor sterile technique can also raise the risk of infection or contamination. Long-term safety data for repeated NAD+ injections remain limited.

References

1. Grant R, et al. “A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD.” Frontiers in Aging Neuroscience. 2019. 

2. Gallagher C, et al. “NAD+ Supplementation for Anti-Aging and Wellness: A Systematic Review of Human Clinical Studies.” Mechanisms of Ageing and Development. 2026.

3. Reyna K, et al. “Intravenous Infusion of Nicotinamide Adenine Dinucleotide and Nicotinamide Riboside in a Commercial Setting.” 2026.

4. de Mello Gindri I, et al. “Evaluation of Safety and Effectiveness of NAD in Different Clinical Conditions: A Systematic Review.” Clinical Nutrition ESPEN. 2024.

5. Zhang J, et al. “The Effect of Nicotinamide Mononucleotide Supplementation on NAD Levels and Health Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” 2025.

6. Yoshino M, et al. “Nicotinamide Mononucleotide Increases Muscle Insulin Sensitivity in Prediabetic Women.” Science. 2021.